SEC Insider Transactions from Kraus Carl N.

Last updated: 2026-03-14 11:09 UTC | Total transactions: 8

Carl N. Kraus, Chief Medical Officer of Aquestive Therapeutics ($AQST), made one open market sale of company shares in the last year, totaling $141,904, with the most recent on October 15, 2025. His sales volume ranks 9,057th among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions. Kraus reported no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Oct. 15, 2025 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer S Common Stock 20272 $7.00 282,475.0000 98,871,369 6.70% 0.02%
Aug. 9, 2025 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer F Common Stock 10819 $3.90 302,747.0000 98,871,369 3.45% 0.01%
March 7, 2025 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer F Common Stock 8115 $2.65 313,566.0000 98,871,369 2.52% 0.01%
March 7, 2025 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer A Non-Qualified Stock Option (right to buy) 30000 $0.00 30,000.0000 98,871,369 9999.99% 0.03%
March 7, 2025 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer A Common Stock 70000 $0.00 321,681.0000 98,871,369 27.81% 0.07%
Aug. 9, 2024 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer F Common Stock 10819 $3.43 251,681.0000 0 4.12% 0.00%
March 7, 2024 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer A Common Stock 112500 $0.00 262,500.0000 0 75.00% 0.00%
March 7, 2024 Aquestive Therapeutics, Inc. $AQST Kraus Carl N Chief Medical Officer A Non-Qualified Stock Option (right to buy) 56250 $0.00 56,250.0000 0 9999.99% 0.00%